Roche poised to enter anti-obesity medication market with agreement to acquire Carmot Therapeutics
top of page
Browse by category
Search
Roche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...
Pemvidutide achieves 15.6% weight loss at 48 weeks
Topline results from the MOMENTUM Phase 2 obesity trial of pemvidutide has shown at week 48, subjects receiving pemvidutide achieved mean...
Night shift workers need support to manage weight and metabolic health
Work based policies must be designed to target barriers that night shift workers face when managing weight and metabolic health...
Clearmind Medicine’s obesity drug shows positive results in a pre-clinical trial
Clearmind Medicine, a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major...
Pfizer’s twice-daily danuglipron formulation to be discontinued after high rates of GI complaints
Topline data from Pfizer’s Phase 2b clinical trial investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate,...
Living with overweight impedes the body's immune response to SARS-CoV-2
Research led by University of Queensland has revealed that living with overweight can impair the body's antibody response to SARS-CoV-2...
US obesity organisations call for better testing and labelling of drugs for people with obesity
The Obesity Action Coalition (OAC) announces the publication of a ‘Joint statement in support of closing gaps in the drug approval...
Browse by tag
bottom of page